Valproic Acid Treatment of Agitation in Dementia

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Canadian journal of psychiatry. Revue canadienne de psychiatrie

• Publication date

  1998-02-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1177/070674379804300108PMID 9494750
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Behavioural Disorders in Demented Elderly Patients

  1996cited by this paper
• Divalproex sodium in the treatment of aggressive behavior and dysphoria in patients with organic brain syndromes.

  1995cited by this paper
• Valproate in the treatment of behavioral agitation in elderly patients with dementia.

  1995cited by this paper
• Valproic Acid for Physically Aggressive Behavior in Geriatric Patients.

  1995cited by this paper
• THE EFFECTS OF SODIUM VALPROATE ON DISTURBED BEHAVIOR IN DEMENTIA

  1994cited by this paper
• Sodium Valproate in the Treatment of Behavioral Disturbance in Dementia

  1993cited by this paper
• Valproate Treatment of Older Psychotic Patients with Organic Mental Syndromes and Behavioral Dyscontrol

  1992cited by this paper
• Pharmacologic management of aggression in the elderly.

  1990cited by this paper
• Behavioral symptoms in Alzheimer's disease: phenomenology and treatment.

  1987cited by this paper
• Agitated Behaviors in the Elderly: II. Preliminary Results in the Cognitively Deteriorated

  1986cited by this paper

• Efficacy of Sodium Valproate in Behavioral and Psychological Symptoms of Dementia: A Retrospective Observational Study from PUMCH Dementia Cohort.

  2025cites this paper
• Bipolar Disorder and Manic-Like Symptoms in Alzheimer’s, Vascular and Frontotemporal Dementia: A Systematic Review

  2022cites this paper
• Effects of magnesium valproate adjuvant therapy on patients with dementia: A systematic review and meta-analysis

  2021cites this paper
• The Black Book of Psychotropic Dosing and Monitoring.

  2018cites this paper
• Alzheimer's Disease and Histone Code Alterations.

  2017cites this paper
• Biomarkers of aggression in dementia.

  2016cites this paper
• Increased acetyl and total histone levels in post-mortem Alzheimer's disease brain.

  2015cites this paper
• Gibt es eine Pharmakotherapie von “herausforderndes Verhalten”?

  2015cites this paper
• Znaczenie układu GABA w patogenezie choroby Alzheimera oraz jako potencjalnego punktu uchwytu działania nowych leków The role of GABA system in pathogenesis of Alzheimer's disease and as a potential new drug target

  2014cites this paper
• Hyperammonemia under the therapeutic range of serum valproic acid concentration in a patient with traumatic brain injury. A case report

  2014cites this paper
• A systematic review of the clinical effectiveness and cost-effectiveness of sensory, psychological and behavioural interventions for managing agitation in older adults with dementia.

  2014cites this paper
• Imaging epigenetics in Alzheimer's disease.

  2013cites this paper
• Dosing of valproate in an elderly population with dementia: Evaluation of discontinuations and dose reductions

  2012cites this paper
• Hyperammonemia associated with valproic acid use in elderly psychiatric patients.

  2012cites this paper
• Valproic Acid in Dementia

  2012cites this paper
• Mood stabilizers for the treatment of behavioral and psychological symptoms of dementia: An update review

  2012cites this paper
• Neuropsychiatrische Störungen bei der Parkinson-Erkrankung

  2012cites this paper
• Psychological Co-morbidities of Dementia

  2011cites this paper
• Pharmacology of epigenetics in brain disorders

  2010cites this paper
• Effects of sodium valproate on behavioral disturbances in elderly outpatients with dementia

  2010cites this paper
• Drug treatments for the behavioural and psychiatric symptoms of dementia

  2010cites this paper
• Agitation in Patients with Dementia - Challenges in Diagnosis and Treatment

  2010cites this paper
• Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection.

  2009cites this paper
• Effect of Oxcarbazepine in the Treatment of Agitation and Aggression in Severe Dementia

  2009cites this paper
• Valproate preparations for agitation in dementia.

  2009cites this paper
• Fármacos antiepilépticos en la enfermedad de Parkinson

  2008cites this paper
• [Role of antiepileptic drugs in Parkinson's disease].

  2008cites this paper
• [Anticonvulsant mood stabilizers in the treatment of behavioral and psychological symptoms of dementia (BPSD)].

  2008cites this paper
• Patient Care and Management of Frontotemporal Lobar Degeneration

  2008cites this paper
• Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: a literature review

  2008cites this paper
• Newer antiepileptic drugs in the management of agitation/aggression in patients with dementia or developmental disability.

  2007cites this paper
• Demenz bei Parkinson-Syndromen: Lewy-Körper-Demenz, idiopathisches und andere Parkinson-Syndrome, Normaldruckhydrozephalus

  2006cites this paper
• Psychosis-related disturbances. Psychosis, agitation, and disinhibition in Alzheimer's disease: definitions and treatment options.

  2006cites this paper
• Divalproex Sodium for the Treatment of Behavioural Problems Associated With Dementia in the Elderly

  2006cites this paper
• Therapeutic Monitoring of Valproate in Psychiatry: How Far Have We Progressed?

  2006cites this paper
• Alzheimer's disease, which is characterized by progressive loss of memory and cognitive function, affects 15 million people worldwide. Mayeux and Sano examine some of the current treatments for this devastating disease.

  2006cites this paper
• Effect of Divalproex Sodium on Behavioural and Cognitive Problems in Elderly Dementia

  2005cites this paper
• The Efficacy of Divalproex Sodium in the Treatment of Agitation Associated With Major Depression

  2005cites this paper
• Valproic acid for agitation in dementia.

  2004cites this paper
• GABAergic Function in Alzheimer's Disease: Evidence for Dysfunction and Potential as a Therapeutic Target for the Treatment of Behavioural and Psychological Symptoms of Dementia

  2004cites this paper
• Alzheimer disease and other dementias.

  2003cites this paper
• New uses for lithium and anticonvulsants.

  2003cites this paper
• Treatment of the neuropsychiatric symptoms in Alzheimer's disease.

  2003cites this paper
• Valproic acid for agitation in dementia.

  2002cites this paper
• Strategies for Optimizing Antiepileptic Drug Therapy in Elderly People

  2002cites this paper
• Pharmacological Treatment of Psychosis and Agitation in Elderly Patients with Dementia

  2002cites this paper
• Sodium valproate in the treatment of aggressive behavior in patients with dementia—a randomized placebo controlled clinical trial

  2002cites this paper
• Tratamento dos transtornos do comportamento de pacientes com demência

  2002cites this paper
• The use of newer anticonvulsants in neuropsychiatric disorders

  2002cites this paper
• Divalproex Sodium Therapy in Elderly with Dementia-Related Agitation

  2002cites this paper
• The Pathophysiology of Agitation

  2001cites this paper
• Delusional misidentification and aggression in Alzheimer's disease.

  2001cites this paper
• Pharmacotherapy of Behavioral and Psychological Symptoms of Dementia: Time for a Different Paradigm?

  2001cites this paper
• Recommendations for the Management of Behavioral and Psychological Symptoms of Dementia

  2001cites this paper
• Clinical and Economic Factors in the Treatment of Behavioural and Psychological Symptoms of Dementia

  2001cites this paper
• Safety and tolerability of divalproex sodium in the treatment of signs and symptoms of mania in elderly patients with dementia: results of a double-blind, placebo-controlled trial

  2001cites this paper
• Treatment of behavioral/psychological symptoms in Alzheimer’s disease

  2001cites this paper
• Evaluating the pharmacokinetics of valproate in the elderly, dose-related changes and their influence on effects

  2001cites this paper
• Placebo-controlled study of divalproex sodium for agitation in dementia.

  2001cites this paper
• The pathophysiology of agitation.

  2000cites this paper
• Comprehensive review of the psychiatric uses of valproate.

  2000cites this paper
• Valproate and the symptomatic treatment of schizophrenia spectrum patients.

  2000cites this paper
• Valproate and the symptomatic treatment of schizophrenia spectrum patients

  2000cites this paper
• Effectiveness of gabapentin for the treatment of behavioral disorders in dementia.

  2000cites this paper
• Effect of treatment with divalproex sodium and lorazepam in residents of long-term-care facilities with dementia-related Anxiety or agitation : Retrospective chart review

  2000cites this paper
• Anticonvulsants to Treat Agitation in Dementia

  2000cites this paper
• Anticonvulsant Use in Treating Dementia-Related Agitation

  2000cites this paper
• Alzheimer's Disease: Pharmacological Treatment and Management

  2000cites this paper
• Neurobehavioral and neuropsychiatric symptoms in Alzheimer's disease: characteristics and treatment.

  2000cites this paper
• A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias.

  2000cites this paper
• Alzheimer’s Disease: Behavioral Management

  1999cites this paper
• Evaluation and management of aggressive behavior in the elderly demented patient.

  1999cites this paper
• Phenomenology and treatment of agitation.

  1999cites this paper
• Bipolar disorder in old age.

  1999cites this paper
• Treatment of Alzheimer's disease.

  1999cites this paper
• The nature and management of mania in old age.

  1999cites this paper
• Behavioral Disturbances of Dementia

  1998cites this paper